Annual report pursuant to Section 13 and 15(d)

ABEONA THERAPEUTICS LLC ACQUISITION (Tables)

v3.7.0.1
ABEONA THERAPEUTICS LLC ACQUISITION (Tables)
 12 Months Ended
Dec. 31, 2016
ABEONA THERAPEUTICS LLC ACQUISITION [Abstract]  
Schedule of purchase price allocation
The following purchase price allocation is as follows:

Total purchase price
      
Initial consideration
  
$
31,758,000
  
Contingent consideration
    
6,489,000
  
Total purchase price
  
$
38,247,000
  
         
Allocation of the purchase price
        
Cash
  
$
3,697,000
  
Accounts receivable
    
1,000
  
Prepaid expenses
    
28,000
  
Property and equipment
    
51,000
  
Other assets
    
1,000
  
Accounts payable
    
(153,000
)
Total tangible assets
    
3,625,000
  
         
Licensing agreement
    
2,156,000
  
Goodwill
    
32,466,000
  
         
Total net asset value
  
$
38,247, 000